Showing results (291-300 of 735) with videos related to

Sort By:
Pageof 74
Annals of Hematology|May 23, 2019
Design and development of a disease-specific quality of life tool for patients with aplastic anaemia and/or paroxysmal nocturnal haemoglobinuria (QLQ-AA/PNH)-a report on phase IIICathrin Niedeggen, Susanne Singer, Martha Groth, et al.
Annals of Hematology|August 17, 2022
Scheduled removal of central venous catheters (CVC) to prevent CVC-related bloodstream infections in patients with hematological disease or autologous stem cell transplantation: a registry-based randomized simulation-studyJens Panse, Daniela Tölle, Eva Fiegle, et al.
Medical Oncology (Northwood, London, England)|November 15, 2011
Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥ 10 g/dL: an exploratory analysis of a phase 3 trialJean-Luc Canon, Johan Vansteenkiste, Michael Hedenus, et al.
Histopathology|April 30, 2015
Loss of RNA-binding motif protein 3 expression is associated with right-sided localization and poor prognosis in colorectal cancerNathaniel Melling, Ronald Simon, Martina Mirlacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
The role of relative lymphocyte count as a biomarker for the effect of catumaxomab on survival in malignant ascites patients: results from a phase II/III studyMarkus M Heiss, Michael A Ströhlein, Carsten Bokemeyer, et al.
Annals of Hematology|February 23, 2008
Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulationFlorian Langer, Brigitte Spath, Katja Haubold, et al.
JMIR Research Protocols|July 30, 2020
Development of a Short Instrument for Measuring Health-Related Quality of Life in Oncological Patients for Clinical Use: Protocol for an Observational StudyTheresa Schrage, Mirja Görlach, Christian Stephan Betz, et al.
JCO Precision Oncology|June 29, 2023
Prognostic Value of Neurotrophic Tyrosine Receptor Kinase Gene Fusions in Solid Tumors for Overall Survival: A Systematic Review and Meta-AnalysisUlrik Lassen, Carsten Bokemeyer, Jesus Garcia-Foncillas, et al.
International Journal of Clinical and Experimental Pathology|September 5, 2015
High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancerTim Hanke, Nathaniel Melling, Ronald Simon, et al.
Molecular Cancer|November 22, 2013
Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathwayLeticia Oliveira-Ferrer, Jasmin Wellbrock, Udo Bartsch, et al.
Pageof 74